Allianz Asset Management GmbH - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 321 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$1,084,000
+134.6%
5,000
+25.0%
0.00%
Q4 2020$462,000
+18.5%
4,0000.0%0.00%
Q3 2020$390,000
-20.4%
4,0000.0%0.00%
-100.0%
Q2 2020$490,000
+12.6%
4,000
+6.2%
0.00%
Q3 2019$435,000
-69.1%
3,765
-53.9%
0.00%
-100.0%
Q2 2019$1,408,000
-4.9%
8,165
-7.0%
0.00%0.0%
Q1 2019$1,480,000
+89.0%
8,780
+8.5%
0.00%0.0%
Q4 2018$783,000
-55.1%
8,090
-19.8%
0.00%
-50.0%
Q3 2018$1,743,000
+23.8%
10,0900.0%0.00%
+100.0%
Q2 2018$1,408,000
+23.8%
10,0900.0%0.00%0.0%
Q1 2018$1,137,000
-14.6%
10,0900.0%0.00%0.0%
Q4 2017$1,332,000
+30.1%
10,0900.0%0.00%0.0%
Q3 2017$1,024,000
+1.7%
10,0900.0%0.00%0.0%
Q2 2017$1,007,000
-18.5%
10,090
-1.1%
0.00%0.0%
Q1 2017$1,235,000
-12.9%
10,200
-19.6%
0.00%0.0%
Q4 2016$1,418,00012,6850.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders